Searched for
ROSUVASTATIN CALCIUM
Largecap stocks with ‘Strong Buy’ and ‘Buy’ recos and upside potential of more than 25%In otherwise volatile markets, bulls are once again making an attempt to come back. There are few large cap stocks which are finding favor ...
Largecap stocks with ‘Strong Buy’ and ‘Buy’ recos and upside potential of more than 25%As the market witnesses volatile movement and bearish bias once again comes back to the street. There are few large cap stocks which are st...
Largecap stocks with ‘Strong Buy’ and ‘Buy’ recos and upside potential of more than 25%As the market witnesses volatile movement and bearish bias once again comes back to the street. There are few large cap stocks which are st...
A consistent wealth creator among 11 stocks that have an upside potential of over 25%As the market witnesses volatile movement there are few large cap stocks which are still finding favor with analysts. After the recent corr...
Twenty three stocks in focus on Wednesday, 02 November 2016Domestic equity markets are likely open lower on Wednesday tracking Nifty futures on the Singapore Stock Exchange (SGX Nifty) and weak glob...
Biocon posts 52% rise in net profit in Q2Expansion of its biologics footprint in emerging markets and licensing agreements boosted the revenue further, according to the company’s m...
Sun Pharma gets FDA nod for rosuvastatin calcium tabletsSun Pharma said: "One of its subsidiaries has received final approval from USFDA for its Abbreviated New Drug Application (ANDA) for generi...
Aurobindo Pharma gets FDA nod for rosuvastatin calcium tabsAurobindo Pharma has received final approval from the US health regulator USFDA for rosuvastatin calcium tablets, used in lowering choleste...
Glenmark gets FDA nod for rosuvastatin calcium tabletsQuoting IMS sales data for the 12 months to May 2016, Glenmark said Rosuvastatin calcium tablets achieved annual sales of around USD 6.78 b...
Europe approves Biocon's Rosuvastatin Calcium tabletsThe approval in the regulated markets marks an important milestone in Biocon's small molecules strategy of forward integration from APIs.
Biggest intra-day gain in 13 months after China allays currency fearsThe Sensex rose 568 points, or 2.47%, to settle at 23,554, with 27 out of the 30 stocks in the index ending in the green.
China's yuan fix, Japan stimulus hopes boost sentiment, drive markets upA turnaround in sentiments helped the Indian market log its biggest intra-day gain in more than a year led by banking and metal stocks.